LEVINE ARNOLD J 4
4 · PMV Pharmaceuticals, Inc. · Filed Jul 22, 2021
Insider Transaction Report
Form 4
LEVINE ARNOLD J
Director
Transactions
- Sale
Common Stock
2021-07-20$35.12/sh−3,500$122,929→ 416,842 total - Award
Stock Option (right to buy)
2021-05-12+5,781→ 5,781 totalExercise: $28.33Exp: 2031-05-11→ Common Stock (5,781 underlying)
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 27, 2021.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.54 to $35.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F3]Shares subject to the option vest in 36 equal monthly installments beginning on June 12, 2021.